We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Allergan Sues Sandoz Over Sanctura XR Patents

Law360 (January 12, 2011, 6:19 PM EST) -- Allergan Inc. and other companies have accused Sandoz Inc. of infringing four patents for overactive bladder drug Sanctura XR.

Allergan contends in a complaint filed Tuesday in the U.S. District Court for the District of Delaware that Sandoz infringed the patents by filing an abbreviated new drug application for a generic version of the medicine, and could further breach them by making and selling the drug before the patents' expiration dates.

Endo Pharmaceuticals Inc., which co-markets Sanctura in the U.S., and Supernus Pharmaceuticals Inc., which owns...
To view the full article, register now.